Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 54 views
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 50 views
- Expect Even More Unique Electric Cars Says Ferrari 44 views
- Kimberly Goldwin Poised to Become Next President of ABC News 30 views
- Records Show 19,000 U.S Based Amazon Employees Contracted Coronavirus 26 views